GESMENE PAUL: Open Payments
NPI 1457744450 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 23 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $397 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 2 | $132 |
| SCPHARMACEUTICALS INC. | 1 | $120 |
| Merck Sharp & Dohme LLC | 6 | $98 |
| Astellas Pharma US Inc | 3 | $69 |
| BridgeBio Pharma, Inc. | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| Medtronic, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Barostim Neo System, FUROSCIX, VERQUVO, Cresemba, Attruby, AMVUTTRA, AURORA EV-ICD MRI SURESCAN, Optimizer.
Industry payments across NJ — which companies pay providers there.
